Harvard seeks to tap soul of leadership

Nov 13, 2006

A "cutting-edge" psychological program is helping Harvard fellows tap into and cultivate their natural leadership capabilities, the Massachusetts school says.

The Leadership Path, created for the Kennedy School of Government's Center for Public Leadership by the Hoffman Institute of San Rafael, Calif., has been shown to help diplomats, politicians, U.N. peacekeepers, educators and other fellows move "into the heart and soul of their intrinsic leadership capabilities" -- which center Executive Director Betsy Myers calls "a more cutting-edge type of leadership."

The program "helps participants reduce emotional reactivity while increasing emotional and spiritual intelligence," said Hoffman President Raz Ingrasci.

"This is what enables the best leaders to consistently make and implement the right decisions in the absence of complete information."

The Hoffman Process underlying the Leadership Path program is supported in a University of California study published in the November issue of Explore: The Journal of Science and Healing.

Copyright 2006 by United Press International

Explore further: Amgen misses 1Q views as higher costs cut profit

add to favorites email to friend print save as pdf

Related Stories

Helping space shuttles achieve liftoff

Jul 08, 2011

Friday’s scheduled liftoff of Space Shuttle Atlantis marks the beginning of the end of nearly four decades of collaboration between MIT and NASA on the nation’s space shuttle program -- a partnership that has shaped ...

Recommended for you

Amgen misses 1Q views as higher costs cut profit

Apr 22, 2014

Despite higher sales, biotech drugmaker Amgen's first-quarter profit fell 25 percent as production and research costs rose sharply, while the year-ago quarter enjoyed a tax benefit. The company badly missed ...

Valeant, Ackman make $45.6B Allergan bid

Apr 22, 2014

Valeant Pharmaceuticals and activist investor Bill Ackman have unveiled details of their offer to buy Botox maker Allergan, proposing a cash-and-stock deal that could be worth about $45.6 billion.

User comments : 0

More news stories

Man among first in US to get 'bionic eye' (Update)

A degenerative eye disease slowly robbed Roger Pontz of his vision. Diagnosed with retinitis pigmentosa as a teenager, Pontz has been almost completely blind for years. Now, thanks to a high-tech procedure ...